David John Harvey

Dr. David John Harvey


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in Mass Spectrometry Reviews
Verified
Journal Article
Closed access
PDF file
DHDavid John Harvey
David John Harvey
PVPaul Vouros
Paul Vouros

12 July 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
CJChunsheng Jin
Chunsheng Jin
DHDavid John Harvey
David John Harvey
WSWeston B. Struwe
Weston B. Struwe
NKNiclas Karlsson
Niclas Karlsson

25 May 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
EMEike Mucha
Eike Mucha
MLMaike Lettow
Maike Lettow
MMMateusz Marianski
Mateusz Marianski
DTDaniel A. Thomas
Daniel A. Thomas
WSWeston B. Struwe
Weston B. Struwe
KPKevin Pagel
Kevin Pagel


24 April 2019 in Endocrinology
Verified
Journal Article
Open access
PDF file
GBGeorge R Bousfield
George R Bousfield
DHDavid John Harvey
David John Harvey
FSH glycosylation varies in two functionally important aspects: microheterogeneity, resulting from oligosaccharide structure variation, and macroheterogeneity, arising from partial FSHβ subunit glycosylation. Although advances in mass spectrometry permit extensive characterization of FSH glycan populations, microheterogeneity remains difficult to illustrate, and comparisons between different studies are challenging because no standard format exists for rendering oligosaccharide structures. FSH microheterogeneity is illustrated using a consistent glycan diagram format to illustrate the large array of structures associated with one hormone. This is extended to commercially available recombinant FSH preparations, which exhibit greatly reduced microheterogeneity at three of four glycosylation sites. Macroheterogeneity is demonstrated by electrophoretic mobility shifts due to the absence of FSHβ glycans that can be assessed by Western blotting of immunopurified FSH. Initially, macroheterogeneity was hoped to matter more than microheterogeneity. However, it now appears that both forms of carbohydrate heterogeneity have to be taken into consideration. FSH glycosylation can reduce its apparent affinity for its cognate receptor by delaying initial interaction with the receptor and limiting access to all of the available binding sites. This is followed by impaired cellular signaling responses that may be related to reduced receptor occupancy or biased signaling. To resolve these alternatives, well-characterized FSH glycoform preparations are necessary.

19 April 2018 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
DHDavid John Harvey
David John Harvey
YWYasunori Watanabe
Yasunori Watanabe
JAJoel D. Allen
Joel D. Allen
PRPauline Rudd
Pauline Rudd
KPKevin Pagel
Kevin Pagel
WSWeston B. Struwe
Weston B. Struwe